Melacare Forte Cream is a topical formulation containing Hydroquinone 4% w/w, Mometasone 0.1% w/w, and Tretinoin 0.025% w/w, indicated for the treatment of hyperpigmentation disorders such as melasma, chloasma, and other pigmentary abnormalities. Hydroquinone acts as a skin-lightening agent by inhibiting tyrosinase, an enzyme essential for melanin synthesis, thereby reducing excessive pigmentation. Mometasone, a potent corticosteroid, exerts anti-inflammatory and immunosuppressive effects, helping to alleviate inflammation and prevent irritation associated with pigmentary conditions. Tretinoin, a retinoid derivative, promotes epidermal cell turnover and enhances the penetration of hydroquinone, facilitating the removal of pigmented keratinocytes and improving skin texture. The combination therapy offers synergistic benefits by addressing multiple pathogenic mechanisms involved in hyperpigmentation. Melacare Forte Cream should be applied as directed by a healthcare professional, typically once daily at night, to clean, dry skin. Caution is advised due to the potential for corticosteroid-related side effects such as skin thinning, and tretinoin-associated irritation or photosensitivity; therefore, concurrent use of sunscreen and avoidance of excessive sun exposure are recommended. This product is intended for short-term use under medical supervision to achieve optimal therapeutic outcomes while minimizing adverse effects.